Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Guillermo Izquierdo"'
Autor:
Edward De Brouwer, Thijs Becker, Lorin Werthen-Brabants, Pieter Dewulf, Dimitrios Iliadis, Cathérine Dekeyser, Guy Laureys, Bart Van Wijmeersch, Veronica Popescu, Tom Dhaene, Dirk Deschrijver, Willem Waegeman, Bernard De Baets, Michiel Stock, Dana Horakova, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Marc Girard, Alexandre Prat, Alessandra Lugaresi, Pierre Grammond, Tomas Kalincik, Raed Alroughani, Francois Grand'Maison, Olga Skibina, Murat Terzi, Jeannette Lechner-Scott, Oliver Gerlach, Samia J Khoury, Elisabetta Cartechini, Vincent Van Pesch, Maria José Sà, Bianca Weinstock-Guttman, Yolanda Blanco, Radek Ampapa, Daniele Spitaleri, Claudio Solaro, Davide Maimone, Aysun Soysal, Gerardo Iuliano, Riadh Gouider, Tamara Castillo-Triviño, José Luis Sánchez-Menoyo, Anneke van der Walt, Jiwon Oh, Eduardo Aguera-Morales, Ayse Altintas, Abdullah Al-Asmi, Koen de Gans, Yara Fragoso, Tunde Csepany, Suzanne Hodgkinson, Norma Deri, Talal Al-Harbi, Bruce Taylor, Orla Gray, Patrice Lalive, Csilla Rozsa, Chris McGuigan, Allan Kermode, Angel Pérez Sempere, Simu Mihaela, Magdolna Simo, Todd Hardy, Danny Decoo, Stella Hughes, Nikolaos Grigoriadis, Attila Sas, Norbert Vella, Yves Moreau, Liesbet Peeters
Publikováno v:
PLOS Digital Health, Vol 3, Iss 7, p e0000533 (2024)
BackgroundDisability progression is a key milestone in the disease evolution of people with multiple sclerosis (PwMS). Prediction models of the probability of disability progression have not yet reached the level of trust needed to be adopted in the
Externí odkaz:
https://doaj.org/article/c8086e53dc844308be0ea446e3a32319
Autor:
Anabel Granja Domínguez, Raúl Romero Sevilla, Aurora Alemán, Carmen Durán, Anja Hochsprung, Guillermo Navarro, Cristina Páramo, Ana Venegas, Ana Lladonosa, Guillermo Izquierdo Ayuso
Publikováno v:
PLoS ONE, Vol 18, Iss 2, p e0272596 (2023)
ObjectiveTo determine the concordance and statistical precision in gait velocity in people with multiple sclerosis (pwMS), measured with FeetMe® (insoles with pressure and motion sensors) compared with GAITRite® (classic reference system of gait an
Externí odkaz:
https://doaj.org/article/87f10896f36840cf9744a5fd9d0393f7
Autor:
José E. Meca-Lallana, Bonaventura Casanova, Alfredo Rodríguez-Antigüedad, Sara Eichau, Guillermo Izquierdo, Carmen Durán, Jordi Río, Miguel Ángel Hernández, Carmen Calles, José M. Prieto-González, José Ramón Ara, Dionisio F. Uría, Lucienne Costa-Frossard, Antonio García-Merino, Celia Oreja-Guevara
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
BackgroundEarly identification of the transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS) can be challenging for clinicians, as diagnostic criteria for SPMS are primarily based on physical disability and a
Externí odkaz:
https://doaj.org/article/aa9c9b31ac3d4967b3581b1660d1bab5
Autor:
José I. Fernández-Velasco, Enric Monreal, Jens Kuhle, Virginia Meca-Lallana, José Meca-Lallana, Guillermo Izquierdo, Celia Oreja-Guevara, Francisco Gascón-Giménez, Susana Sainz de la Maza, Paulette E. Walo-Delgado, Paloma Lapuente-Suanzes, Aleksandra Maceski, Eulalia Rodríguez-Martín, Ernesto Roldán, Noelia Villarrubia, Albert Saiz, Yolanda Blanco, Carolina Diaz-Pérez, Gabriel Valero-López, Judit Diaz-Diaz, Yolanda Aladro, Luis Brieva, Cristina Íñiguez, Inés González-Suárez, Luis A Rodríguez de Antonio, José M. García-Domínguez, Julia Sabin, Sara Llufriu, Jaime Masjuan, Lucienne Costa-Frossard, Luisa M. Villar
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
ObjectiveTo ascertain the role of inflammation in the response to ocrelizumab in primary-progressive multiple sclerosis (PPMS).MethodsMulticenter prospective study including 69 patients with PPMS who initiated ocrelizumab treatment, classified accord
Externí odkaz:
https://doaj.org/article/c8e040513ca84c5f9b5252521e717dd6
Autor:
Antonio Bertolotto, Rafael Arroyo, Elisabeth G. Celius, Giancarlo Comi, Eva Kubala Havrdova, William David Honeycutt, Samuel F. Hunter, Guillermo Izquierdo, Barbara Kornek, Tamara Miller, Dimos D. Mitsikostas, Barry A. Singer, Tjalf Ziemssen, Luke Chung, Nadia Daizadeh, Salman Afsar, Lobat Hashemi, Peter Senior
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 443-457 (2020)
Plain Language Summary This study looked at alemtuzumab, an approved treatment for multiple sclerosis (MS). People who receive alemtuzumab may develop thyroid problems. The researchers wanted to know whether people who developed thyroid problems with
Externí odkaz:
https://doaj.org/article/3bcc37fc46e84de69be4eb2c49df7148
Publikováno v:
International Journal of Interactive Multimedia and Artificial Intelligence, Vol 5, Iss 6, Pp 48-53 (2019)
Multiple sclerosis is an idiopathic inflammatory disease of the central nervous system and the second most common cause of disability in young adults. Choosing an effective treatment is crucial to preventing disability. However, response to treatment
Externí odkaz:
https://doaj.org/article/b030ff2aa85e42bda27bccda9b0e8f85
Autor:
Francisco Carlos Pérez‐Miralles, Daniel Prefasi, Antonio García‐Merino, José Ramón Ara, Guillermo Izquierdo, Virginia Meca‐Lallana, Francisco Gascón‐Giménez, María Luisa Martínez‐Ginés, Lluis Ramió‐Torrentà, Lucienne Costa‐Frossard, Óscar Fernández, Sara Moreno‐García, Jorge Maurino, Joan Carreres‐Polo, Bonaventura Casanova
Publikováno v:
Brain and Behavior, Vol 11, Iss 4, Pp n/a-n/a (2021)
Abstract Background and purpose Evidence on regional changes resulting from neurodegenerative processes underlying primary progressive multiple sclerosis (PPMS) is still limited. We assessed brain region volumes and their relationship with disability
Externí odkaz:
https://doaj.org/article/1c68c742d928479ab6b1cd9c261aafe7
Autor:
Inmaculada Toboso, Amalia Tejeda-Velarde, Roberto Alvarez-Lafuente, Rafael Arroyo, Harald Hegen, Florian Deisenhammer, Susana Sainz de la Maza, José C. Alvarez-Cermeño, Guillermo Izquierdo, Dolores Paramo, Pedro Oliva, Bonaventura Casanova, Eduardo Agüera-Morales, Diego Franciotta, Matteo Gastaldi, Oscar Fernández, Patricia Urbaneja, José M. Garcia-Dominguez, Fernando Romero, Alicia Laroni, Antonio Uccelli, Angel Perez-Sempere, Albert Saiz, Yolanda Blanco, Daniela Galimberti, Elio Scarpini, Carmen Espejo, Xavier Montalban, Ludwig Rasche, Friedemann Paul, Inés González, Elena Álvarez, Cristina Ramo, Ana B. Caminero, Yolanda Aladro, Carmen Calles, Pablo Eguía, Antonio Belenguer-Benavides, Lluis Ramió-Torrentà, Ester Quintana, José E. Martínez-Rodríguez, Agustín Oterino, Carlos López de Silanes, Luis I. Casanova, Lamberto Landete, Jette Frederiksen, Gabriel Bsteh, Patricia Mulero, Manuel Comabella, Miguel A. Hernández, Mercedes Espiño, José M. Prieto, Domingo Pérez, María Otano, Francisco Padilla, Juan A. García-Merino, Laura Navarro, Alfonso Muriel, Lucienne Costa Frossard, Luisa M. Villar
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Overview: We assessed the role of age and disease activity as new factors contributing to establish the risk of progressive multifocal leucoencephalopathy in multiple sclerosis patients treated with natalizumab in 36 University Hospitals in Europe. W
Externí odkaz:
https://doaj.org/article/c82f6fa684d240fe86a6b469a1788aa1
Autor:
Francisco Barrero, Javier Mallada-Frechin, María Luisa Martínez-Ginés, María Eugenia Marzo, Virginia Meca-Lallana, Guillermo Izquierdo, José Ramón Ara, Celia Oreja-Guevara, José Meca-Lallana, Lucía Forero, Irene Sánchez-Vera, María José Moreno, in representation of the MS NEXT study investigators
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230846 (2020)
PurposeThe objective of this study was to characterize the demographic and clinical profile of RRMS patients receiving fingolimod in Spain, and to evaluate drug effectiveness and safety in clinical practice.MethodsThis observational, retrospective, m
Externí odkaz:
https://doaj.org/article/35e01650c3644a1095a86b39b5d34dd7
Autor:
Andres Keller, Pablo Wagner, Guillermo Izquierdo, Jorge Cabrolier, Nathaly Caicedo, Emilio Wagner, Nicola Maffulli
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 13, Iss 1, Pp 1-7 (2018)
Abstract Background The purpose of this study is to translate, culturally adapt, and validate the VISA-A questionnaire for Chilean Spanish speakers with Achilles tendinopathy (AT), which has been originally developed for English-speaking population.
Externí odkaz:
https://doaj.org/article/e13ea524ea6944babd1904750ea08ccf